{"id":203507,"name":"SAGE THERAPEUTICS","slug":"sage-therapeutics","state":"MA","country":"United States of America","description":"","totalSpending":4824277,"filings":28,"yearlySpending":[{"year":2019,"income":589013},{"year":2020,"income":894752},{"year":2021,"income":1034756},{"year":2022,"income":1225756},{"year":2023,"income":510000},{"year":2024,"income":570000}],"issues":["MMM","BUD","CPT","HCR","PHA","TRD","MED"],"firms":["SAGE THERAPEUTICS"],"lobbyists":["VANESSA PROCTER","JULIE GARNER","MARGARET MANN"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","Office of the Vice President of the United States","Substance Abuse & Mental Health Services Administration (SAMHSA)"],"sampleDescriptions":["Maternal Mental Health \nMajor Depressive Disorder\nMental Illness\nDrug Pricing \nDrug Price Transparency \nMedicaid Reform \nMedicare Reform\nInsurance Coverage \nValue Based Care \nIP Reform","Maternal Mental Health \nMajor Depressive Disorder\nMental Illness\nDrug Pricing \nDrug Price Transparency \nMedicaid Reform \nMedicare Reform\nInsurance Coverage \nValue Based Care \nIP Reform","Maternal Mental Health \nMajor Depressive Disorder\nMental Illness\nDrug Pricing \nDrug Price Transparency \nMedicaid Reform \nMedicare Reform\nInsurance Coverage \nValue Based Care \nIP Reform","Maternal Mental Health \nMajor Depressive Disorder\nMental Illness\nDrug Pricing \nDrug Price Transparency \nMedicaid Reform \nMedicare Reform\nInsurance Coverage \nValue Based Care \nIP Reform","Maternal Mental Health \nMajor Depressive Disorder\nMental Illness\nDrug Pricing \nDrug Price Transparency \nMedicaid Reform \nMedicare Reform\nInsurance Coverage \nValue Based Care \nIP Reform"],"years":[2019,2020,2021,2022,2023,2024]}